| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0005930 | axoneme | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HMY9
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_PCSK_SKI1_1 | 35 | 39 | PF00082 | 0.730 |
| CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.694 |
| DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.581 |
| DOC_WW_Pin1_4 | 47 | 52 | PF00397 | 0.600 |
| DOC_WW_Pin1_4 | 98 | 103 | PF00397 | 0.435 |
| LIG_14-3-3_CanoR_1 | 35 | 45 | PF00244 | 0.505 |
| LIG_14-3-3_CanoR_1 | 5 | 10 | PF00244 | 0.582 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.759 |
| LIG_FHA_1 | 4 | 10 | PF00498 | 0.494 |
| LIG_FHA_1 | 55 | 61 | PF00498 | 0.657 |
| LIG_FHA_1 | 87 | 93 | PF00498 | 0.560 |
| LIG_FHA_1 | 99 | 105 | PF00498 | 0.606 |
| LIG_FHA_2 | 27 | 33 | PF00498 | 0.626 |
| LIG_LIR_LC3C_4 | 43 | 48 | PF02991 | 0.721 |
| LIG_LIR_Nem_3 | 106 | 112 | PF02991 | 0.610 |
| LIG_SH2_SRC | 107 | 110 | PF00017 | 0.658 |
| LIG_SH2_STAP1 | 84 | 88 | PF00017 | 0.437 |
| LIG_SH3_3 | 13 | 19 | PF00018 | 0.593 |
| LIG_SH3_3 | 45 | 51 | PF00018 | 0.590 |
| LIG_SUMO_SIM_anti_2 | 43 | 50 | PF11976 | 0.701 |
| LIG_SUMO_SIM_par_1 | 43 | 50 | PF11976 | 0.604 |
| LIG_TRAF2_1 | 143 | 146 | PF00917 | 0.640 |
| LIG_TRAF2_1 | 156 | 159 | PF00917 | 0.607 |
| MOD_CK1_1 | 26 | 32 | PF00069 | 0.484 |
| MOD_CK1_1 | 4 | 10 | PF00069 | 0.650 |
| MOD_CK1_1 | 69 | 75 | PF00069 | 0.622 |
| MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.702 |
| MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.657 |
| MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.625 |
| MOD_GSK3_1 | 1 | 8 | PF00069 | 0.650 |
| MOD_GSK3_1 | 36 | 43 | PF00069 | 0.658 |
| MOD_GSK3_1 | 92 | 99 | PF00069 | 0.649 |
| MOD_N-GLC_1 | 118 | 123 | PF02516 | 0.445 |
| MOD_N-GLC_1 | 69 | 74 | PF02516 | 0.606 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.713 |
| MOD_NEK2_1 | 103 | 108 | PF00069 | 0.547 |
| MOD_NEK2_1 | 130 | 135 | PF00069 | 0.662 |
| MOD_NEK2_1 | 75 | 80 | PF00069 | 0.569 |
| MOD_NEK2_1 | 86 | 91 | PF00069 | 0.454 |
| MOD_NEK2_1 | 96 | 101 | PF00069 | 0.575 |
| MOD_PIKK_1 | 130 | 136 | PF00454 | 0.667 |
| MOD_PK_1 | 5 | 11 | PF00069 | 0.577 |
| MOD_PKA_2 | 4 | 10 | PF00069 | 0.620 |
| MOD_Plk_1 | 69 | 75 | PF00069 | 0.438 |
| MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.578 |
| MOD_ProDKin_1 | 47 | 53 | PF00069 | 0.599 |
| MOD_ProDKin_1 | 98 | 104 | PF00069 | 0.435 |
| TRG_DiLeu_BaEn_1 | 122 | 127 | PF01217 | 0.585 |
| TRG_DiLeu_BaEn_4 | 145 | 151 | PF01217 | 0.473 |
| TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.624 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PCS8 | Leptomonas seymouri | 52% | 95% |
| A0A1X0P5D6 | Trypanosomatidae | 38% | 100% |
| A0A3S7X9I9 | Leishmania donovani | 79% | 98% |
| A4IBL3 | Leishmania infantum | 79% | 98% |
| C9ZZ27 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 98% |
| E9AFE6 | Leishmania major | 77% | 100% |
| E9B6K1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 99% |
| V5BD44 | Trypanosoma cruzi | 37% | 99% |